Literature DB >> 10780954

GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation.

Z Lin1, J M Weinberg, R Malhotra, S E Merritt, L B Holzman, F C Brosius.   

Abstract

Many studies have suggested that enhanced glucose uptake protects cells from hypoxic injury. More recently, it has become clear that hypoxia induces apoptosis as well as necrotic cell death. We have previously shown that hypoxia-induced apoptosis can be prevented by glucose uptake and glycolytic metabolism in cardiac myocytes. To test whether increasing the number of glucose transporters on the plasma membrane of cells could elicit a similar protective response, independent of the levels of extracellular glucose, we overexpressed the facilitative glucose transporter GLUT-1 in a vascular smooth muscle cell line. After 4 h of hypoxia, the percentage of cells that showed morphological changes of apoptosis was 30.5 +/- 2.6% in control cells and only 6.0 +/- 1.1 and 3.9 +/- 0.3% in GLUT-1-overexpressing cells. Similar protection against cell death and apoptosis was seen in GLUT-1-overexpressing cells treated for 6 h with the electron transport inhibitor rotenone. In addition, hypoxia and rotenone stimulated c-Jun-NH(2)-terminal kinase (JNK) activity >10-fold in control cell lines, and this activation was markedly reduced in GLUT-1-overexpressing cell lines. A catalytically inactive mutant of MEKK1, an upstream kinase in the JNK pathway, reduced hypoxia-induced apoptosis by 39%. These findings show that GLUT-1 overexpression prevents hypoxia-induced apoptosis possibly via inhibition of stress-activated protein kinase pathway activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780954     DOI: 10.1152/ajpendo.2000.278.5.E958

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  18 in total

1.  GLUT1-induced cFLIP expression promotes proliferation and prevents apoptosis in vascular smooth muscle cells.

Authors:  Eileen D Vesely; Charles W Heilig; Frank C Brosius
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-08       Impact factor: 4.249

2.  Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.

Authors:  Itaru Chiba; Kazuhiko Ogawa; Takamitsu Morioka; Hideaki Shimoji; Nao Sunagawa; Shiro Iraha; Tadashi Nishimaki; Naomi Yoshimi; Sadayuki Murayama
Journal:  Oncol Lett       Date:  2010-10-27       Impact factor: 2.967

3.  Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt.

Authors:  B Keith; D M Adelman; M C Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

4.  The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer.

Authors:  Daniel J Inglis; Tina C Lavranos; Donna M Beaumont; Annabell F Leske; Chloe K Brown; Allison J Hall; Gabriel Kremmidiotis
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

5.  5'-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumors.

Authors:  Keith R Laderoute; Joy M Calaoagan; Wan-Ru Chao; Dominc Dinh; Nicholas Denko; Sarah Duellman; Jessica Kalra; Xiaohe Liu; Ioanna Papandreou; Lidia Sambucetti; Laszlo G Boros
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

Review 6.  The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications.

Authors:  Elena Bernobich; Luisa de Angelis; Carlos Lerin; Giuseppe Bellini
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Glucose utilization is essential for hypoxia-inducible factor 1 alpha-dependent phosphorylation of c-Jun.

Authors:  Keith R Laderoute; Joy M Calaoagan; Merrill Knapp; Randall S Johnson
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 8.  Hypoxia-inducible factor-1 in tumour angiogenesis.

Authors:  Yong-Hong Shi; Wei-Gang Fang
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

9.  Cardiac metabolic compensation to hypertension requires lipoprotein lipase.

Authors:  Haruyo Yamashita; Kalyani G Bharadwaj; Shota Ikeda; Tae-Sik Park; Ira J Goldberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-22       Impact factor: 4.310

10.  Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.

Authors:  Cheng-Jun Hu; Li-Yi Wang; Lewis A Chodosh; Brian Keith; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.